Since the advent of advanced genomics, and the subsequent rise of automation, the data generated in clinical testing and research sees a 100 fold increase each year making the storage, security and management of patient data quite a daunting task for companies to mine the data to find the factors that drive a patient’s disease. That’s where BioDiscovery comes in. Their flagship solution NxClinical, is a unique software tool for integrated analysis of copy number, sequence variants, and allelic changes obtained from multiple technologies. The solution combines NGS and Array data through advanced mining and filtering techniques which allows the data to be clear and digestible for clinicians.
Ambry Genetics selects BioDiscovery’s NxClinical software for analysis, management, and reporting of copy number events in its clinical genomics workflow.
Illumina Selects BioDiscovery’s NxClinical Software for Data Visualization, Management and Interpretation for its CytoSeq ™ assay, an NGS-based Solution for Detection of CNVs, AOH, and SNVs
CombiMatrix is now using BioDiscovery’s NxClinical software for analysis, management, and interpretation of copy number events in its clinical workflow.
Recognized leader in research and education, and one of the top pediatric providers in the Midwest recently started using NxClinical.
A genomics services provider for clinical trials, testing, and research will now be working with BioDiscovery in a co-marketing partnership.
NxClinical 2.0 is a flexible, platform-agnostic database solution for efficient analysis, interpretation, and reporting of variations.